Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 8153 - 8160 of 12007 results

Massachusetts Ranks Second and Boston Ranks Seventh in the 2016 U.S. Clean Tech Leadership Index

May 23, 2016| Blog| Viewpoint

Competitors in the Courtroom: When to Exclude a Party’s Designated Representative from Hearing a Competitor’s Trade Secrets

May 23, 2016| Blog| Viewpoint

Check Your Inbox: OCR Continues to Verify Entity Contact Information for Phase 2 HIPAA Audits

May 23, 2016| Blog| Viewpoint

5 Ways to Ease the Pain of an Antitrust Review

May 23, 2016| News

When Does A CPSC Late Reporting Violation First Accrue?

May 23, 2016| News

Good News on "Bad Boy" Guarantees; IRS Reverts to Prior Position in Recent Legal Advice Memorandum (ML Tax and Real Estate Alert)

May 23, 2016| Blog| Viewpoint

USDA Increases Cane Sugar Imports to Meet Demand for Non-GE Products

May 23, 2016| Blog| Viewpoint

Law360: In The ACA Age, Employee Handbooks Can Help — Or Hurt

May 20, 2016| Blog| Viewpoint

News & Press Releases

Mintz Advises ArriVent BioPharma on $75 Million Underwritten Public Offering

July 08, 2025

Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“

Mintz Advises S2G Investments on $40M Series B Financing of Sojo Industries

July 07, 2025

Mintz represented S2G Investments, a multi-stage investment firm focused on venture and growth-stage businesses across food & agriculture, oceans and energy, in its $40 million Series B financing of Sojo Industries, an industrial automation company that utilizes robotics, mobility, and software to deliver packaging and assembly solutions to the food and beverage industry.

Mintz Advises Syntis Bio on $33 Million Series A Financing

July 02, 2025

Mintz advised Syntis Bio, a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes, and rare diseases, on a $33 million oversubscribed Series A financing.

View all News and Press Releases